RE: Slift16 Dec 2020 22:46
bopd, john4242,
I really don't understand your skepticism.
The company has even addressed your queries in Q&A:
"What has been the key stumbling block to increasing sales of KPFértil?
We do not consider there has been a "stumbling block" in the sales rate of KPFértil. In the space of only several years, Harvest has progressed from a grass roots discovery to breakeven, with a near term expectation of profitability. In the Board's eyes, this is a remarkable achievement and one that has not been emulated by any other small cap AIM quoted company that Harvest is aware of.
During 2018, Harvest announced two sales contracts, which have not performed as hoped; that has created an expectation gap, which has disappointed the market. Whilst this is not satisfactory, it is also old news in the context of the Company's evolution and continuing to refer to that old news is not benefitting anyone. Looking at the present and immediate future, the Company has reached a sizeable sales run rate that it expects to improve on next year as it reaches profitability. Ordinarily, a profitable, dividend-paying company, which Harvest is targeting, will be re-rated by the market as it meets the investment criteria of a broader investor base."
Reading this, now that Harvest is predicted to post a profit this year, I wonder if they will announce a dividend for next year?
To me as a new investor, it looks like a turnaround is happening.
The board is doing all that they have said:
- Target sales
- Increase capacity of plant
- Breakeven 2019
- Profit 2020 (TBA in Q4 update)
- Continuous growth with market targetted (Sugarcane results, more results to follow)
- etc.
Again the only negatives I can say for HMI going forwards is cashflow.
What am i not seeing?